Skip to content

Optimization of the Construction Methods for Tumor Organoid Models Based on the Human Thoracic Cavity and Research on the Application of Such Organoid Models in Assisting Tumor Drug Screening

Optimization of the Construction Methods for Tumor Organoid Models Based on the Human Thoracic Cavity and Research on the Application of Such Organoid Models in Assisting Tumor Drug Screening

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500102010
Enrollment
Unknown
Registered
2025-05-07
Start date
2025-05-25
Completion date
Unknown
Last updated
2025-05-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thoracic Cancer

Interventions

Observation group:None

Sponsors

The Second Affiliated Hospital of Soochow University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Single thoracic tumor without distant metastasis; 2.Patients who have not undergone neoadjuvant therapy or other antitumor treatments; 3.Patients without autoimmune diseases.

Exclusion criteria

Exclusion criteria: 1.Patients with distant metastasis or tumors other than thoracic tumors; 2.Patients who have received any form of antitumor treatment prior to surgery; 3.Patients with autoimmune diseases or other conditions deemed by researchers as potentially affecting the study outcomes.

Design outcomes

Primary

MeasureTime frame
Objective response rate, ORR;

Secondary

MeasureTime frame
Overall survival;

Countries

China

Contacts

Public ContactYonghua Sang

The Second Affiliated Hospital of Soochow University

5323961212@qq.com+86 135 0353 6679

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026